Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
VHIR
Menu
A long-lasting anti-Covid-19 subcutaneous vaccine through a novel, industrially competitive and biologically safe nanomimetic concept (INVITA)
Share
Tweet
Share
Pin
Close Menu
VHIR
Home
Six Top Stories
Highlights
Research Areas
Facts & Figures
Partners and Acknowledgements
WIDER
Download Summary
VHIR Annual Report 2021